| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |